Q THERAPEUTICS

q-therapeutics-logo

Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment of degenerative diseases of the brain and spinal cord. The company develops Q-Cells that is intended for the treatment of amyotrophic lateral sclerosis, multiple sclerosis, transverse myelitis, traumatic spinal cord injury, and Parkinsonโ€™s disease, as well as for Alzheimerโ€™s disease, traumatic brain injury, cerebral palsy, Leukodystrophies and central nervous system storage diseases, and peripheral neuropathies. Q Therapeutics is headquartered in Salt Lake City, Utah.

#SimilarOrganizations #People #Financial #Website #More

Q THERAPEUTICS

Social Links:

Industry:
Biotechnology Health Care Therapeutics

Founded:
2004-01-01

Address:
Salt Lake City, Utah, United States

Country:
United States

Website Url:
http://www.qthera.com

Total Employee:
1+

Status:
Active

Contact:
801-582-5400

Email Addresses:
[email protected]

Total Funding:
24.22 M USD

Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Apple Mobile Web Clips Icon Content Delivery Network Microsoft Exchange Online Office 365 Mail JsDelivr Microsoft Azure DNS


Similar Organizations

apellis-pharmaceuticals-logo

Apellis Pharmaceuticals

Apellis Pharmaceuticals focusesย on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.

excision-biotherapeutics-logo

Excision BioTherapeutics

Excision is developing CRISPR-based therapies to cure viral infectious diseases and improve the lives of chronically ill patients.

Current Employees Featured

deborah-a-eppstein_image

Deborah A. Eppstein
Deborah A. Eppstein Director, President & CEO @ Q Therapeutics
Director, President & CEO

mahendra-rao_image

Mahendra Rao
Mahendra Rao Scientific Co-founder, Chief Strategy Officer @ Q Therapeutics
Scientific Co-founder, Chief Strategy Officer

not_available_image

Steven J. Borst
Steven J. Borst Chief Financial Officer @ Q Therapeutics
Chief Financial Officer

Founder


mahendra-rao_image

Mahendra Rao

Acquisitions List

Date Company Article Price
2016-11-28 Degania Medical Degania Medical acquired by Q Therapeutics N/A

Investors List

university-of-utah-endowment_image

University of Utah Endowment

University of Utah Endowment investment in Venture Round - Q Therapeutics

epic-ventures_image

EPIC Ventures

EPIC Ventures investment in Venture Round - Q Therapeutics

salt-lake-life-science-angels_image

Salt Lake Life Science Angels

Salt Lake Life Science Angels investment in Venture Round - Q Therapeutics

qmanagement_image

Q management

Q management investment in Venture Round - Q Therapeutics

toucan-capital_image

Toucan Capital

Toucan Capital investment in Venture Round - Q Therapeutics

vspring-capital_image

vSpring Capital

vSpring Capital investment in Venture Round - Q Therapeutics

Official Site Inspections

http://www.qthera.com

  • Host name: 147.62.236.23.bc.googleusercontent.com
  • IP address: 23.236.62.147
  • Location: Mountain View United States
  • Latitude: 37.4043
  • Longitude: -122.0748
  • Metro Code: 807
  • Timezone: America/Los_Angeles
  • Postal: 94043

Loading ...

More informations about "Q Therapeutics"

Home | qthera

Q Therapeutics has adopted a unique approach to developing human cell-based therapies for debilitating โ€“ and currently incurable โ€“ diseases of the brain and spinal cord (the central โ€ฆSee details»

About - qthera

Dr. Parks brings to Q Therapeutics more than 30 years experience in life science research and its translation into therapeutic products. As a faculty member in the Department of Neurobiology โ€ฆSee details»

Q Therapeutics - Crunchbase Company Profile & Funding

Contact Email [email protected] Phone Number 801-582-5400 Q Therapeutics is a development stage company, engages in the development of human cell-based therapies for the treatment โ€ฆSee details»

Q Therapeutics Company Profile 2024: Valuation, Funding

Q Therapeutics General Information Description. Developer of novel stem cell therapy intended to treat debilitating CNS disease and injury. The company's cell therapies replace the insulating โ€ฆSee details»

Investors | qthera

See details»

Q Therapeutics - LinkedIn

Q Therapeutics | 440 followers on LinkedIn. Q has developed a human cell based therapeutic product to treat degenerative disorders of the brain and spinal cord. | Q Therapeutics is a โ€ฆSee details»

Q Therapeutics - Overview, News & Similar companies - ZoomInfo

Www.qthera.com. Revenue <$5 Million. Industry Manufacturing General Manufacturing . Recent News & Media. InVivo Therapeutics Announces Joint Research Collaboration w... Oct 2, 2018. โ€ฆSee details»

qthera.com - Home | qthera - Qthera - Sur.ly

Qthera.com most likely does not offer any adult content. Popular pages. Home | qthera Q-Cells® โ€“ our first cellular therapeutic candidate โ€“ are human glial progenitor cells that give rise to two โ€ฆSee details»

Goodwin biotech partners with Q Thera in ALS treatment project.

Jul 13, 2015 Goodwin Biotechnology is a biological contract development and manufacturing organization (CDMO) that offers cell line development, exploratory proof of concept projects, โ€ฆSee details»

Quethera - Crunchbase Company Profile & Funding

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases. Our initial focus is on developing therapies to reduce progressive visual โ€ฆSee details»

Pipeline - qthera

Q Therapeutics has a deep pipeline, with significant market potential backed by a strong intellectual property position. Q Therapeutics is actively preparing for first-in-human clinical โ€ฆSee details»

FDA Allows Q-Cells (R) for First-In-Human Transverse Myelitis Trial

Jul 25, 2017 Q Therapeutics, Inc., developer of clinical-stage cell therapies for central nervous system disease and injury, announced U.S. Food and Drug Administration allowance of its โ€ฆSee details»

QUALTHERA

At Qualthera, we are dedicated to providing innovative, custom medication solutions for both healthcare providers and patients. Our mission is to deliver quality therapy for life, ensuring โ€ฆSee details»

Quethera - Contacts, Employees, Board Members, Advisors & Alumni

Quethera is a gene therapy company dedicated to improving the future treatment of common blinding eye diseases.See details»

Therapeutic Focus | qthera

Our initial targets are orphan diseases, such as transverse myelitis and ALS, which benefit from an accelerated FDA approval process and market exclusivity.See details»

Quthero.com

In wounded skin, Q-peptide treatment accelerates cell migration and leads to a unique profile of cytokine secretion, enabling faster healing and deposition of new collagen.Q-peptide treatment โ€ฆSee details»

Quethera Company Profile 2024: Valuation, Investors ... - PitchBook

Quethera General Information Description. Developer of gene therapy technologies designed to improve the treatment of common blinding eye diseases. The company's technology focuses โ€ฆSee details»

Technology - qthera

The most common types of glial cells in the brain are: Astrocytes โ€“ Specialized cells that protect neurons by producing growth factors, removing toxins, protecting against damage, modulating โ€ฆSee details»

qthera.net

Qthera.netSee details»

News - qthera

Aug 21, 2014 Reversing Paralysis: Stem cell therapy aims to repair spinal cords afflicted by rare disorder. Oct 8, 2018, 8:00 AM EDT InVivo Therapeutics Announces Joint Research โ€ฆSee details»

linkstock.net © 2022. All rights reserved